P.2.038 Influence of pegylated interferon-alpha on the nitric oxide system in high-risk melanoma patients

2005 ◽  
Vol 15 ◽  
pp. S408
Keyword(s):  
Nitric Oxide ◽  
High Risk ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Oxide System ◽  
Pegylated Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients ◽  
Nitric Oxide System

scholarly journals CN4 COST-EFFECTIVENESS (CE) ANALYSIS OF INTERFERON-ALPHA IN HIGH-RISK MELANOMA PATIENTS

2004 ◽  
Vol 7 (3) ◽  
pp. 221 ◽  
Author(s):  
M Ding ◽  
Y Xing ◽  
T Shih ◽  
D Cox ◽  
S Cantor ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients

P14 Outcome of high risk melanoma patients treated with low dose interferon alpha 2B

1999 ◽  
Vol 9 (3) ◽  
pp. 328
Author(s):  
D. A. Vorobiof ◽  
D. E. Ostria ◽  
G. Vorobiof ◽  
M. R. Chasen
Keyword(s):  
High Risk ◽  
Interferon Alpha ◽  
Low Dose ◽  
Interferon Alpha 2B ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients

Influence of immunotherapy with interferon-alpha on serum amino acids, biopterin and neopterin in high risk melanoma patients

2002 ◽  
Vol 12 ◽  
pp. 242
Author(s):  
A.R. Van Gool ◽  
D. Fekkers ◽  
W.H.J. Kruit ◽  
T.L.M. Ten Hagen ◽  
M. Bannink ◽  
...  
Keyword(s):  
Amino Acids ◽  
High Risk ◽  
Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Serum Amino Acids ◽  
Melanoma Patients

Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients

2003 ◽  
Vol 119 (1-2) ◽  
pp. 125-132 ◽  
Author(s):  
Arthur R. Van Gool ◽  
Durk Fekkes ◽  
Wim H.J. Kruit ◽  
Paul G.H. Mulder ◽  
Timo L.M. Ten Hagen ◽  
...  
Keyword(s):  
Amino Acids ◽  
High Risk ◽  
Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Serum Amino Acids ◽  
Melanoma Patients

Pattern of restoration of the immune alterations by the treatment with high doses of Interferon alpha in high risk melanoma patients

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7534-7534
Author(s):  
E. Reyes ◽  
M. Arroyo ◽  
T. Portugal ◽  
A. B. Mallo ◽  
F. Navarro ◽  
...  
Keyword(s):  
High Risk ◽  
Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Immune Alterations ◽  
Melanoma Patients ◽  
High Doses

Pattern of restoration of the immune alterations by the treatment with high doses of Interferon alpha in high risk melanoma patients

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7534-7534
Author(s):  
E. Reyes ◽  
M. Arroyo ◽  
T. Portugal ◽  
A. B. Mallo ◽  
F. Navarro ◽  
...  
Keyword(s):  
High Risk ◽  
Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Immune Alterations ◽  
Melanoma Patients ◽  
High Doses

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

2017 ◽  
Vol 67 (2) ◽  
pp. 285-298 ◽  
Author(s):  
Olivier Gasser ◽  
Katrina J. Sharples ◽  
Catherine Barrow ◽  
Geoffrey M. Williams ◽  
Evelyn Bauer ◽  
...  
Keyword(s):  
T Cells ◽  
Dendritic Cells ◽  
High Risk ◽  
Phase I ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients ◽  
Polyfunctional T Cells

Neoadjuvant Systemic Therapy for High-Risk Melanoma Patients

2020 ◽  
pp. 767-793
Author(s):  
Emily Z. Keung ◽  
Rodabe N. Amaria ◽  
Vernon K. Sondak ◽  
Merrick I. Ross ◽  
John M. Kirkwood ◽  
...  
Keyword(s):  
High Risk ◽  
Systemic Therapy ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Neoadjuvant Systemic Therapy ◽  
Melanoma Patients
Sign in / Sign up

Export Citation Format

Share Document